financetom
Business
financetom
/
Business
/
Lexeo Therapeutics Raises $95 Million Via Private Placement of Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lexeo Therapeutics Raises $95 Million Via Private Placement of Shares
Mar 13, 2024 3:20 PM

05:54 PM EDT, 03/13/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Wednesday it sold 6.3 million common shares in a private placement at $15.13 each, for gross proceeds of $95 million.

The company said it plans to use the net proceeds to fund ongoing clinical-stage programs, for working capital and general corporate purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nano Dimension Launches Strategic Review, Names New CEO
Nano Dimension Launches Strategic Review, Names New CEO
Sep 9, 2025
07:38 AM EDT, 09/09/2025 (MT Newswires) -- Nano Dimension ( NNDM ) said Tuesday that its board has launched a strategic review to evaluate a range of options to maximize shareholder value. The company said it has hired Guggenheim Partners and Houlihan Lokey as exclusive financial advisors to support the process. As part of the changes, Nano Dimension ( NNDM...
Energy Fuels Says its Rare Earths From Utah Manufactured Into Permanent Magnets for EVs
Energy Fuels Says its Rare Earths From Utah Manufactured Into Permanent Magnets for EVs
Sep 9, 2025
07:39 AM EDT, 09/09/2025 (MT Newswires) -- Energy Fuels ( UUUU ) said Tuesday that high-purity neodymium-praseodymium oxide produced at its White Mesa Mill in Utah has been manufactured into commercial scale rare earth permanent magnets and passed all quality benchmarks for use in EV drive unit motors. These drive units are expected to be installed in new vehicles and...
Market Chatter: OpenAI Leaders Concerned Over Restructuring Plan Pressure, Weigh California Exit
Market Chatter: OpenAI Leaders Concerned Over Restructuring Plan Pressure, Weigh California Exit
Sep 9, 2025
07:42 AM EDT, 09/09/2025 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI executives are increasingly concerned that political pressure in California that could derail their plan to become a for-profit company and have discussed relocating out of the state as a last-resort option, The Wall Street Journal reported Monday, citing sources it didn't identify. Philanthropies, nonprofits, and labor groups...
Ionis Pharmaceuticals Says US FDA Grants ION582 Orphan Drug Designation to Treat Rate Neurological Disease
Ionis Pharmaceuticals Says US FDA Grants ION582 Orphan Drug Designation to Treat Rate Neurological Disease
Sep 9, 2025
07:41 AM EDT, 09/09/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said Tuesday that the US Food and Drug Administration has granted Breakthrough Therapy designation to ION582 to treat patients with Angelman syndrome, a rare neurological disease. The company said the designation is based on a phase 1/2 study of ION582 that showed consistent and encouraging clinical improvement. Ionis...
Copyright 2023-2026 - www.financetom.com All Rights Reserved